ArticleJournal of minimal access surgery2025
Robotic sleeve gastrectomy in a woman with class V obesity, cirrhosis and portal hypertension: A step forward.
Article in Journal of minimal access surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractThe increasing prevalence of obesity has made managing metabolic-dysfunction-associated steatotic liver disease and metabolic-dysfunction-associated steatohepatitis (MASH) with cirrhosis a significant challenge. This report details the case of a 53-year-old woman with class-V obesity (body mass index: 63.9 kg/m²) and MASH-associated decompensated cirrhosis with portal hypertension who underwent robotic sleeve gastrectomy (SG) after preoperative optimisation. Initial management involved stabilisation of variceal bleeding, a very-low-calorie diet, beta-blockers and continuous positive airway pressure, leading to improved liver function and Child-Turcotte-Pugh class improvement from B to A. The robotic SG, performed with meticulous intraoperative techniques to minimise bleeding and good post-operative care, resulted in favourable outcomes, including significant weight loss (44.8% total body weight loss) and improved liver parameters at 18-months. This case highlights the feasibility of metabolic and bariatric surgery in carefully selected cirrhotic patients following comprehensive optimisation and multidisciplinary care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.